TOX / Thymocyte selection-associated high mobility group box protein TOX · Western blot design guide

Design a Western Blot for TOX

Real validated TOX Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TOX WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for TOX: expected band ~57.5 kDa, hero antibody A08441-2, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable TOX Western blot protocol sheet — expected band ~57.5 kDa, antibody A08441-2, controls and PMC citations. Open the full TOX WB guide →

TOX Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~57.5 kDa
Observed band ~57 kDa
Gel 5–20% (catalog A08441-2)
Positive control ⓘ Appendix (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM —
Caveat —
Gene-set association MSigDB C7 membership
Isoform 1 isoform(s)
Section 1

Real Curated TOX Western Blot Protocols

The A08441-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman Jurkat, human Ramos, human HL-60 (catalog A08441-2)
Gel %5–20% (catalog A08441-2)
Load30 ug; reducing conditions (catalog A08441-2)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A08441-2)
Membranenitrocellulose membrane (catalog A08441-2)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A08441-2)
Primary antibodyA08441-2 · 0.5 μg/mL (catalog A08441-2)
Primary incubationovernight at 4°C (catalog A08441-2)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A08441-2)
Secondary incubation1.5 hour at RT (catalog A08441-2)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A08441-2)
DetectionECL (catalog A08441-2)
Section 2

What Is the Expected TOX Western Blot Band Size?

TOX is predicted at 57.5 kDa and observed near 57 kDa; the cause of the small difference is not established.

What am I looking at on my blot?
Band near 57 kDa in whole-cell lysateMatches the observed TOX band
Single band near 57 kDaConsistent with the predicted 57.5 kDa mass
Band near 57 kDa in a nuclear fractionConsistent with TOX's nuclear location
Little signal near 57 kDa in a cytoplasmic fractionConsistent with TOX's nuclear location
💡Expected TOX appearanceTOX has a predicted mass of 57.5 kDa and an observed band near 57 kDa; confirm band identity with appropriate controls.
How each factor affects band size
Predicted molecular mass of 57.5 kDaPlaces the expected full-length band near 57.5 kDa
UniProt molecular weight of 57,513 DaCorresponds to approximately 57.5 kDa
Full-length predicted massProvides the baseline for comparing other band positions
Predicted TOX protein sizeIs consistent with the observed band near 57 kDa
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateNuclear TOX may be poorly recovered during extractionCheck extraction and probe a nuclear fraction
Band higher than expectedThe supplied features do not establish a larger TOX formCheck band identity with an independent TOX antibody
Band lower than expectedThe supplied features do not establish a smaller TOX formCheck band identity with an independent TOX antibody
Multiple bandsThe supplied features do not establish distinct migrating TOX formsCompare bands using an independent TOX antibody
Weak or no signalNuclear TOX may be poorly represented in the tested fractionCheck loading and probe a nuclear fraction

Sample controls for TOX Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for TOX in Western blot, you can use appendix tissue, which HPA rates High for TOX.
Positive control: Appendix (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: TOX is nuclear, so a nuclear-enriched lysate may improve detection.

HPA tissue expression evidence for TOX

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Appendix lymphoid tissue High Protein (IHC) HPA →
Kidney collecting ducts High Protein (IHC) HPA →
Lymph node germinal center cells High Protein (IHC) HPA →
Testis sertoli cells High Protein (IHC) HPA →
Tonsil germinal center cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Caudate glial cells Not detected Protein (IHC) HPA →
Cerebellum cells in granular layer Not detected Protein (IHC) HPA →
Epididymis glandular cells Not detected Protein (IHC) HPA →
Fallopian tube glandular cells Not detected Protein (IHC) HPA →
Section 3

Advanced TOX Western Blot Tips

Deeper troubleshooting and optimisation questions for TOX, answered from its protein features.

How should TOX band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could TOX isoforms explain additional bands?
Isoforms · The supplied UniProt features list one isoform and no alternative sequence. They provide no basis for assigning additional bands to TOX isoforms.
Do annotated modifications prove a band shift?
PTM · The linked UniProt record describes protein features. A modification annotation alone does not demonstrate a visible shift; retain any condition or experimental qualifier attached to it.
Does this guide establish induction of TOX?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for TOX Western blot?
Transfer · Plan transfer around the reported ~57 kDa band and check transfer at that size with a marker or total-protein stain. The supplied features do not specify a special transfer method.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A08441-2 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should TOX be quantified across samples?
Quantitation · Measure the ~57 kDa band in comparable samples or nuclear fractions. Use a consistent loading reference for the fraction analyzed; TOX's nuclear annotation makes fraction consistency particularly relevant.
How does the observed TOX band compare with its predicted mass?
Interpretation · TOX is predicted at 57.5 kDa, close to the reported ~57 kDa band. This agreement supports the expected band position, but mass alone does not establish identity.

TOX is annotated as nuclear. Include a nuclear fraction when checking for its ~57 kDa band, and compare like fractions across samples.

Check whether the ~57 kDa band is present before assigning other bands to TOX. The supplied features list no alternative sequence, modified residues, or glycosylation sites, so they do not establish an identity or cause for extra bands.
Boster reagents

TOX Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of TOX using anti-TOX antibody (A08441-2). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Jurkat whole cell lysates, Lane 2: human Ramos whole cell lysates, Lane 3: human HL-60 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-TOX antigen affinity purified polyclonal antibody (Catalog # A08441-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for TOX at approximately 57 kDa. The expected band size for TOX is at 57 kDa.
Anti-TOX Antibody Picoband®
Cat # A08441-2

The catalog reports one anti-TOX antibody, A08441-2, with reported Human and Mouse reactivity. Its Western blot image shows an approximately 57 kDa band in human Jurkat, Ramos, and HL-60 whole cell lysates. No mouse Western blot sample is shown.

Which to pick: A08441-2 is the only listed option. It has a Western blot image using human cell lysates at 30 µg per lane; Mouse reactivity is listed, but this image does not test a mouse sample.

Source: BosterBio TOX gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.